Skip to main content

Moderna Slides After FDA Delays Youth Vaccine Decision Due To Heart Inflammation Issues

The agency plans to further review data before deciding on whether to extend the vaccine's eligibility to younger people.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.